Steady-state kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-87201E

Area of Science:

• Biochemistry
• Virology
• Enzymology

Background:

• Human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) is a crucial enzyme for viral replication.
• HIV-1 RT possesses distinct RNA- and DNA-directed DNA polymerase activities, alongside RNase H function.
• Understanding the inhibition mechanisms of HIV-1 RT is vital for developing antiviral therapies.

Purpose of the Study:

• To investigate the inhibitory mechanism of the bisheteroarylpiperazine U-87201E on HIV-1 RT.
• To determine whether U-87201E targets the template:primer or deoxyribonucleotide triphosphate (dNTP) binding sites.
• To elucidate the differential sensitivity of HIV-1 and HIV-2 RT to U-87201E.

Main Methods:

• Enzymatic kinetic studies using steady-state kinetics.
• Analysis of ordered, processive polymerase reaction kinetics.
• Determination of inhibition patterns with respect to substrate binding sites.

Main Results:

• U-87201E inhibits both RNA- and DNA-directed DNA polymerase activities of HIV-1 RT but not its RNase H function.
• Kinetic data suggest that both polymerase functions share common substrate-binding sites.
• U-87201E exhibits noncompetitive inhibition concerning both nucleic acid and dNTP binding sites, indicating interaction with a distinct site.
• HIV-1 RT is uniquely sensitive to U-87201E, while HIV-2 RT is insensitive.

Conclusions:

• U-87201E is a potent inhibitor of HIV-1 RT polymerase activities, binding to an allosteric site.
• The inhibitor demonstrates differential potency between RNA- and DNA-directed polymerase functions.
• The unique sensitivity of HIV-1 RT highlights potential for targeted antiviral drug development.